Using biomarkers to predict the presence of FAS mutations in patients with features of the autoimmune lymphoproliferative syndrome - Wikidata - wikimedia - TriplyDB

Using biomarkers to predict the presence of FAS mutations in patients with features of the autoimmune lymphoproliferative syndrome

Using biomarkers to predict the presence of FAS mutations in patients with features of the autoimmune lymphoproliferative syndrome

http://www.wikidata.org/entity/Q24623046

about

Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop How I treat autoimmune lymphoproliferative syndrome Biomarkers and Algorithms for the Diagnosis of Vitamin B12 Deficiency Approaches to Managing Autoimmune Cytopenias in Novel Immunological Disorders with Genetic Underpinnings Like Autoimmune Lymphoproliferative Syndrome Autoimmune lymphoproliferative syndrome: an update and review of the literature FAS haploinsufficiency is a common disease mechanism in the human autoimmune lymphoproliferative syndrome Autoimmune lymphoproliferative syndrome misdiagnosed as hemophagocytic lymphohistiocytosis Diagnosis and management of autoimmune cytopenias in childhood.Updated Understanding of Autoimmune Lymphoproliferative Syndrome (ALPS).Elevated interleukin-10: a new cause of dyslipidemia leading to severe HDL deficiency Somatic FAS mutations are common in patients with genetically undefined autoimmune lymphoproliferative syndrome.Somatic KRAS mutations associated with a human nonmalignant syndrome of autoimmunity and abnormal leukocyte homeostasis New advances in the diagnosis and treatment of autoimmune lymphoproliferative syndrome Gene defects in the soma: some get it and some don't!IL-10/Janus kinase/signal transducer and activator of transcription 3 signaling dysregulates Bim expression in autoimmune lymphoproliferative syndrome The expanding spectrum of the autoimmune lymphoproliferative syndromes Loss-of-function of the protein kinase C δ (PKCδ) causes a B-cell lymphoproliferative syndrome in humans Diagnosis of autoimmune lymphoproliferative syndrome caused by FAS deficiency in adults.Autoimmune lymphoproliferative syndrome caused by a homozygous null FAS ligand (FASLG) mutation.Sequential decisions on FAS sequencing guided by biomarkers in patients with lymphoproliferation and autoimmune cytopenia.Natural history of autoimmune lymphoproliferative syndrome associated with FAS gene mutations Advances in autoimmune lymphoproliferative syndromes.Diagnostic approach to primary immunodeficiency disorders.Optimal Management of Autoimmune Lymphoproliferative Syndrome in Children.Restimulation-induced cell death: new medical and research perspectives.Decreased activation-induced cell death by EBV-transformed B-cells from a patient with autoimmune lymphoproliferative syndrome caused by a novel FASLG mutation.Evolution of disease activity and biomarkers on and off rapamycin in 28 patients with autoimmune lymphoproliferative syndrome.Autoimmune lymphoproliferative syndrome: a multifactorial disorder.Gray platelet syndrome can mimic autoimmune lymphoproliferative syndrome.Novel insights into FAS defects underlying autoimmune lymphoproliferative syndrome revealed by studies in consanguineous patients.

P2860

Q24632569-16E7A043-8BBB-4575-AB40-9B26D1DB959F Q24633207-3215BF5D-0A32-4216-87B0-109B3F6F9E99 Q26742072-AEA19428-AB6E-4CF8-A840-16B3D5B87572 Q26799956-D699E699-6103-46E9-A73A-0DFA6D14502E Q26825740-B2028E31-EFC5-4B97-955D-3D7FCEE8D15C Q28235519-2BD60C94-42B3-4B98-9CD7-7A97608BCB36 Q28299956-14CA1111-B105-4DD5-B9DD-DC61A9FA8990 Q33411497-20954977-B85A-4C1F-999F-A0977F312D7D Q33420245-7B416836-4B50-4F92-90E5-B999351CE0D9 Q33910884-3599C50B-7D32-434F-9B16-F46ECE741106 Q33944255-74C5622B-769F-4D9D-8D42-3F38461D7F78 Q34149957-04F8ABCF-5509-4914-A32C-5DC0A0A4A7A2 Q34239719-59DF79E3-B7F6-4B29-9934-8104976C6930 Q34429062-AC83C983-19CD-4E23-AEE1-DC66CBCD1D31 Q35130847-DC718C29-B486-4A6E-AC02-74B2230597DB Q35619447-154DAA02-0FF9-48A0-8556-642EC3CF2732 Q36779397-C62ED92A-5C6E-4F66-AB25-9E4ED29575A2 Q36862333-951119FB-9BD2-4E30-9D5A-804C929F426D Q37298573-BF2DAC43-DAC0-43EA-B513-B827945D8358 Q37377927-241495C0-9DBE-4447-95B2-AA961B806DB7 Q37670054-AB755D7F-EB05-4074-9623-AE04EED21660 Q37859077-1E861B18-D518-407A-B7AB-94D65BCC73FE Q38128689-F9EFB660-7E19-44C2-8099-5F5424ACFA9A Q38823961-489BF0F0-5D1E-4A29-90D8-1781FDA0E23B Q39277444-FFB43363-A341-4AFD-8F74-D89684F6B9AF Q41428240-BEE84FD1-5B20-49E8-91A8-88683546F5DD Q42325007-C9DD96DF-81B7-42E8-8893-3DC0A0F6A380 Q42392801-A614C3DB-FF93-4628-A48F-673D7159081A Q43124182-4E4C9FD8-AF09-40EB-82BF-D342A7AA1AF7 Q49973525-DA4017FD-BD09-458B-9ACA-EDF4C8A6CC7B

P2860

Using biomarkers to predict the presence of FAS mutations in patients with features of the autoimmune lymphoproliferative syndrome

http://www.wikidata.org/entity/Q24623046

description

2010 nî lūn-bûn

@nan

2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Using biomarkers to predict th ...... e lymphoproliferative syndrome

@ast

Using biomarkers to predict th ...... e lymphoproliferative syndrome

@en

Using biomarkers to predict th ...... e lymphoproliferative syndrome

@nl

type

label

Using biomarkers to predict th ...... e lymphoproliferative syndrome

@ast

Using biomarkers to predict th ...... e lymphoproliferative syndrome

@en

Using biomarkers to predict th ...... e lymphoproliferative syndrome

@nl

prefLabel

Using biomarkers to predict th ...... e lymphoproliferative syndrome

@ast

Using biomarkers to predict th ...... e lymphoproliferative syndrome

@en

Using biomarkers to predict th ...... e lymphoproliferative syndrome

@nl

P1433

Q24623046-73D910CC-379C-4C61-942F-79796EDA31F7

P1476

Q24623046-161E4216-A9E8-4CA6-A22B-1157AB85C517

P2093

Q24623046-07ABD6FA-3791-4433-8344-6E9483769697

Q24623046-2B8DF853-699F-4748-8916-1CA629B37365

Q24623046-423FCCF3-B521-4445-B46C-50C7385288A1

Q24623046-5D90E2C4-ABAF-43AE-9E73-534F23C18474

Q24623046-71A4B241-2984-47E4-BCAF-64AA501CEB3A

Q24623046-746FA085-0E3B-4525-8A21-13B66B460BC2

Q24623046-87D40133-1E92-4433-93B0-B21D8B003EEE

Q24623046-97D89E6C-F495-4A7A-9F10-CF6F763FA929

Q24623046-D1CD2687-4CA4-44A5-8D24-EE4E2D712383

Q24623046-F433E1A4-10A6-47A1-A20F-A2CBBCE2BB82

P2860

Q24623046-49E01510-0D58-46A0-A8E9-F42FEDE5E134

Q24623046-5A66BF19-89DF-438A-8918-FC781647C0E8

Q24623046-9F8C02A6-04E9-47EC-ABC5-61FDFC56BB2F

Q24623046-CFBE9F20-BD95-4EE0-A491-A48A649E9A4E

Q24623046-FEBCCFC2-3A83-4AE3-8EB4-C0E6AF6C9E1F

P304

Q24623046-9ACEC90D-3227-43C9-9062-E0341B8DC9AB

P31

Q24623046-C17045D9-1F53-4825-97E7-498D5BA72AAB

P3181

Q24623046-27614848-2ABE-469E-862C-CCA305D3CDE4

P356

Q24623046-4F520CB4-8ABC-4640-BDB8-A0790AA9D4A1

P407

Q24623046-7F71839D-BADF-494C-A97D-5BFAB542EC06

P433

Q24623046-E83EB326-951A-482E-BB03-75FC7B928BF3

P478

Q24623046-CF995861-DADB-40EB-BD95-5D340738E808

P50

Q24623046-64186F69-F437-45C3-B291-DFE77470C785

Q24623046-65916EBA-F37D-43A7-8596-829C56D74525

P577

Q24623046-E395A2B9-6A58-426B-9A79-D908D6833DCD

P5875

Q24623046-EFE58C01-45BE-4DAC-A0B1-81F322972EF1

P698

Q24623046-86F0B55B-363E-417F-8619-6E886935F9FE

P921

Q24623046-22C9CC35-ACAB-4C0E-A224-7986B7B55B47

Q24623046-77E292D8-F514-448F-A163-36EFA19C64A5

Q24623046-DF3E862C-D52B-49C1-93CF-1514F21AD887

P932

Q24623046-C7DF11CE-FB4D-458B-9516-BB68E8AC93EF

P3181

P356

J.JACI.2009.12.983

P1433

The Journal of Allergy and Clinical Immunology

P1476

Using biomarkers to predict th ...... e lymphoproliferative syndrome

@en

P2093

Iusta Caminha

http://www.w3.org/2001/XMLSchema#string

Janet K Dale

http://www.w3.org/2001/XMLSchema#string

Joie Davis

http://www.w3.org/2001/XMLSchema#string

Katie Perkins

http://www.w3.org/2001/XMLSchema#string

Kennichi C Dowdell

http://www.w3.org/2001/XMLSchema#string

Margaret R Brown

http://www.w3.org/2001/XMLSchema#string

Ronald L Hornung

http://www.w3.org/2001/XMLSchema#string

Susan Price

http://www.w3.org/2001/XMLSchema#string

Thomas A Fleisher

http://www.w3.org/2001/XMLSchema#string

V Koneti Rao

http://www.w3.org/2001/XMLSchema#string

P2860

FAS-L, IL-10, and double-negative CD4- CD8- TCR alpha/beta+ T cells are reliable markers of autoimmune lymphoproliferative syndrome (ALPS) associated with FAS loss of function

Autoimmune lymphoproliferative syndrome with defective Fas: genotype influences penetrance

A novel lymphoproliferative/autoimmune syndrome resembling murine lpr/gld disease.

NRAS mutation causes a human autoimmune lymphoproliferative syndrome.

Genetic disorders of programmed cell death in the immune system.

P304

946-949.e6

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

483410

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/J.JACI.2009.12.983

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

125

http://www.w3.org/2001/XMLSchema#string

P50

Julie E. Niemela

Joao B. Oliveira

P577

2010-03-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41943271

http://www.w3.org/2001/XMLSchema#string

P698

20227752

http://www.w3.org/2001/XMLSchema#string

P921

autoimmune lymphoproliferative syndrome

P932

3412519

http://www.w3.org/2001/XMLSchema#string